💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Artist ends lawsuit over Shkreli's one-of-a-kind Wu-Tang album

Published 05/04/2016, 10:56 AM
Updated 05/04/2016, 11:00 AM
© Reuters. File photo of Shkreli, former CEO of Turing Pharmaceuticals LLC, appearing before a hearing in Washington

NEW YORK (Reuters) - An artist from Long Island, New York has ended his lawsuit blaming indicted drug executive Martin Shkreli and Wu-Tang Clan leader Robert "RZA" Diggs for stealing his illustrations for a one-of-a-kind album that Shkreli bought for $2 million.

Jason Koza, of Copiague, New York, on Tuesday dismissed his copyright infringement case against Diggs, Wu Tang producer Tarik "Cilvaringz" Azzougarh and Paddle8 NY LLC, which auctioned the "Once Upon a Time in Shaolin" album to Shkreli in November.

"The dispute has been resolved," Koza's lawyer Peter Scoolidge said in an email on Wednesday. He declined to elaborate.

Stephen Rothschild, a lawyer for Diggs, was not immediately available for comment on Wednesday.

Shkreli had been dropped from the case on April 18. The former chief of Turing Pharmaceuticals is known for having sparked outrage last year when he raised the price of the anti-parasitic infection drug Daraprim by more than 5,000 percent.

Koza, a Fashion Institute of Technology graduate, sued Diggs after finding his art had been used in the packaging of "Shaolin," and Shkreli for letting three works depicting other Wu-Tang members accompany a Jan. 29 article at Vice.com.

Shkreli has bragged that he had no plans to listen to the hip-hop group's album, but bought it to "keep it from the people."

He has pleaded not guilty to fraud charges announced in December, which are unrelated to Daraprim.

© Reuters. File photo of Shkreli, former CEO of Turing Pharmaceuticals LLC, appearing before a hearing in Washington

The case is Koza v Diggs et al, U.S. District Court, Southern District of New York, No. 16-00956.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.